财中社11月19日电诺辉健康(06606)发布自愿性公告,宣布其三款产品已根据香港医疗仪器行政管理制度成功注册。这三款产品包括常卫清、噗噗管和幽幽管,分别用于结直肠癌的筛查和幽门螺杆菌检测。随着香港政府推出结直肠癌筛查计划,并资助50至75岁无症状居民接受筛查,市场对早期癌症筛查的意识和需求正在不断提高。
此外,公司股份自2024年3月28日起在联交所暂停买卖,并将继续暂停,直至满足复牌指引。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.